Canadian marijuana company Aphria (NASDAQ: APHA) is often viewed as a (relatively) safe pot stock pick. Aphria’s peers, including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), have recently gone on acquisition and expansion sprees, scaring some investors away with rapid growth strategy implementation. Aphria has noted their examples, and is instead taking an asset-light approach to business and focusing on…
Exclusive Interview with Aphria CEO Irwin Simon The strength of Aphria’s (TSX: APHA) (NASDAQ: APHA) brands, team and grow facilities are helping it to stand out in the cannabis industry, according to CEO Irwin Simon. He spoke with New Cannabis Ventures about the profitable company’s global strategy and its positioning for further growth. The audio […] READ MORE: https://www.newcannabisventures.com/aphria-looks-to-brand-power-to-continue-driving-its-global-strategy/
Net Cannabis Revenue Increased 103% from Prior Year QuarterAdjusted EBITDA from Cannabis Business of $10.4 Million Increased 11% from Prior QuarterCash Cost Per Gram Remained Below $1.00 and Decreased for the Fourth Consecutive Quarter to $0.87 LEAMINGTON, ON, Oct. 15, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA) (Nasdaq: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very…
Aphria on Thursday reported mixed fiscal first-quarter earnings as adult-use cannabis prices remained under pressure. Aphria stock and other marijuana stocks sold off. Estimates: Zacks forecasts a loss of around 4 Canadian cents per share, as revenue jumps 24% to 155.49 million Canadian dollars. READ MORE: https://finance.yahoo.com/m/0c3ac96f-be58-34b9-aa4b-2f3ad0f816f9/marijuana-stocks-fall-as.html?.tsrc=rss
Aphria Inc. Announces Record Adult-Use Cannabis Gross Revenue in First Quarter Fiscal Year 2021 and Sixth Consecutive Quarter of Positive Adjusted EBITDA Net Cannabis Revenue Increased 103% from Prior Year Quarter Adjusted EBITDA from Cannabis Business of $10.4 Million Increased 11% from Prior Quarter Cash Cost Per Gram Remained Below $1.00 and Decreased for the […] READ MORE: https://www.newcannabisventures.com/aphria-q1-cannabis-revenue-advances-18-sequentially/
Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May’s total sales. Despite their historic difficulties in generating cash, paying off debts, and avoiding massive writedowns, Aphria (NASDAQ: APHA) and Aurora Cannabis (NYSE: ACB) could be poised…
One with strong financial backing, another with consistent profits — which of these two Canadian pot stocks is a better pick? READ MORE: https://finance.yahoo.com/m/d8053e80-2214-3d85-b83c-653fc21fc078/better-cannabis-stock:-canopy.html?.tsrc=rss
Challenges in the marijuana industry are nothing new; profitability, in particular, has always been an issue for the Canadian pot companies. Ontario-based Aphria (NASDAQ: APHA), however, is bucking the trend with a track record of consistent profitability over the past five consecutive quarters. Aphria cultivates and sells medical and recreational cannabis products, with a compelling product portfolio that includes brands like…
During the coronavirus pandemic, many U.S. locales deemed cannabis an essential item, and the resultant surge in sales brought revenue pouring in for several marijuana companies. Sequential growth from the prior quarter, however, was a mere 2%, and revenue from the Canadian recreational market sank 11% to CA$44.2 million, challenged by the pandemic-era retail operating environment. READ MORE: https://finance.yahoo.com/m/e902ccff-ccfc-3892-9954-799b8d2428a0/better-marijuana-stock:.html?.tsrc=rss
Last year, marijuana investors still would have likely considered cannabis companies Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) to be the industry leaders in the Canadian pot market. Although Aphria was a big name in the cannabis industry a year ago, investors weren’t considering it in the same breath as Aurora or Canopy Growth. A year ago, Aphria’s market cap was about…
Canopy Growth (NYSE: CGC) and Aphria (NASDAQ: APHA) are two heavyweights in the Canadian pot market. For a long time, cannabis investors saw Canopy Growth as the leader in the industry, but that just isn’t the case anymore. At the very least, the company’s got some tight competition not only from Aphria but also from U.S.-based pot stocks that are growing in size…
The company also announced a US$100 million, or about C$133.7 million, at-the-market stock sale program. READ MORE: https://finance.yahoo.com/m/79b6a748-fa9e-3f91-8ab5-3bb899104057/aphria-leads-pot-stock.html?.tsrc=rss